Compara mètodes

	Anàlisi d'Enriquiment de Conjunts de Gens en Sèries Temporals	Expressió Diferencial en RNA-seq
Camp	Bioinformàtica	Bioinformàtica
Família	Process / pipeline	Process / pipeline
Any d'origen	2005 (GSEA foundation); time-series adaptations 2007–2014	2008–2010 (RNA-seq DE methodology established)
Autor original	Extension of GSEA (Subramanian et al., 2005); time-series adaptations developed through maSigPro (Conesa lab) and related tools	Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010)
Tipus	Gene set enrichment method for longitudinal omics data	Quantitative genomics pipeline
Font seminal	Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550.	Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550.
Àlies	longitudinal GSEA, dynamic GSEA, time-course GSEA, TS-GSEA	RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA
Relacionats	6	6
Resum	Time-series gene set enrichment analysis (TS-GSEA) extends the classical GSEA framework to detect biologically coordinated gene sets — pathways, gene ontology terms, or curated signatures — whose collective expression changes meaningfully over time. Rather than comparing two snapshots, it models the full temporal trajectory of gene expression to identify which functional programs are activated, suppressed, or dynamically remodelled during a biological process such as development, treatment response, or disease progression.	RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values.